Highlights

[OCR] QoQ Quarter Result on 2017-07-31 [#0]

Stock [OCR]: OCR GROUP BHD
Announcement Date 28-Sep-2017
Admission Sponsor -
Sponsor -
Financial Year 31-Jul-2017
31-Jul-2017
Profit Trend QoQ -     28.42%    YoY -     151.00%
Quarter Report


View:


Show?  QoQ % Horiz. %

Quarter Result
31/01/18 31/12/17 31/10/17 31/07/17 30/04/17 31/01/17 31/10/16 CAGR
Revenue 21,362 0 21,519 24,609 23,436 28,772 11,956 58.97%
  QoQ % 0.00% 0.00% -12.56% 5.01% -18.55% 140.65% -
  Horiz. % 178.67% 0.00% 179.98% 205.83% 196.02% 240.65% 100.00%
PBT 1,524 0 2,530 1,784 2,492 2,020 335 235.34%
  QoQ % 0.00% 0.00% 41.82% -28.41% 23.37% 502.99% -
  Horiz. % 454.93% 0.00% 755.22% 532.54% 743.88% 602.99% 100.00%
Tax -603 0 -363 -1,413 -1,430 -1,017 -66 485.27%
  QoQ % 0.00% 0.00% 74.31% 1.19% -40.61% -1,440.91% -
  Horiz. % 913.64% -0.00% 550.00% 2,140.91% 2,166.67% 1,540.91% 100.00%
NP 921 0 2,167 371 1,062 1,003 269 167.24%
  QoQ % 0.00% 0.00% 484.10% -65.07% 5.88% 272.86% -
  Horiz. % 342.38% 0.00% 805.58% 137.92% 394.80% 372.86% 100.00%
NP to SH -745 0 1,062 1,378 1,073 990 288 -
  QoQ % 0.00% 0.00% -22.93% 28.42% 8.38% 243.75% -
  Horiz. % -258.68% 0.00% 368.75% 478.47% 372.57% 343.75% 100.00%
Tax Rate 39.57 % - % 14.35 % 79.20 % 57.38 % 50.35 % 19.70 % 74.55%
  QoQ % 0.00% 0.00% -81.88% 38.03% 13.96% 155.58% -
  Horiz. % 200.86% 0.00% 72.84% 402.03% 291.27% 255.58% 100.00%
Total Cost 20,441 0 19,352 24,238 22,374 27,769 11,687 56.29%
  QoQ % 0.00% 0.00% -20.16% 8.33% -19.43% 137.61% -
  Horiz. % 174.90% 0.00% 165.59% 207.39% 191.44% 237.61% 100.00%
Net Worth 95,102 98,800 90,789 89,449 90,608 90,579 88,800 5.63%
  QoQ % -3.74% 8.82% 1.50% -1.28% 0.03% 2.00% -
  Horiz. % 107.10% 111.26% 102.24% 100.73% 102.04% 102.00% 100.00%
Dividend
31/01/18 31/12/17 31/10/17 31/07/17 30/04/17 31/01/17 31/10/16 CAGR
Div - - - - - - - -
  QoQ % 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -
  Horiz. % - - - - - - -
Div Payout % - % - % - % - % - % - % - % -
  QoQ % 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -
  Horiz. % - - - - - - -
Equity
31/01/18 31/12/17 31/10/17 31/07/17 30/04/17 31/01/17 31/10/16 CAGR
Net Worth 95,102 98,800 90,789 89,449 90,608 90,579 88,800 5.63%
  QoQ % -3.74% 8.82% 1.50% -1.28% 0.03% 2.00% -
  Horiz. % 107.10% 111.26% 102.24% 100.73% 102.04% 102.00% 100.00%
NOSH 279,712 267,029 267,029 241,754 238,444 238,366 240,000 13.01%
  QoQ % 4.75% 0.00% 10.45% 1.39% 0.03% -0.68% -
  Horiz. % 116.55% 111.26% 111.26% 100.73% 99.35% 99.32% 100.00%
Ratio Analysis
31/01/18 31/12/17 31/10/17 31/07/17 30/04/17 31/01/17 31/10/16 CAGR
NP Margin 4.31 % - % 10.07 % 1.51 % 4.53 % 3.49 % 2.25 % 68.06%
  QoQ % 0.00% 0.00% 566.89% -66.67% 29.80% 55.11% -
  Horiz. % 191.56% 0.00% 447.56% 67.11% 201.33% 155.11% 100.00%
ROE -0.78 % - % 1.17 % 1.54 % 1.18 % 1.09 % 0.32 % -
  QoQ % 0.00% 0.00% -24.03% 30.51% 8.26% 240.63% -
  Horiz. % -243.75% 0.00% 365.62% 481.25% 368.75% 340.63% 100.00%
Per Share
31/01/18 31/12/17 31/10/17 31/07/17 30/04/17 31/01/17 31/10/16 CAGR
RPS 7.64 - 8.06 10.18 9.83 12.07 4.98 40.75%
  QoQ % 0.00% 0.00% -20.83% 3.56% -18.56% 142.37% -
  Horiz. % 153.41% 0.00% 161.85% 204.42% 197.39% 242.37% 100.00%
EPS -0.27 0.00 0.40 0.57 0.45 0.42 0.12 -
  QoQ % 0.00% 0.00% -29.82% 26.67% 7.14% 250.00% -
  Horiz. % -225.00% 0.00% 333.33% 475.00% 375.00% 350.00% 100.00%
DPS 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -
  QoQ % 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -
  Horiz. % - - - - - - -
NAPS 0.3400 0.3700 0.3400 0.3700 0.3800 0.3800 0.3700 -6.53%
  QoQ % -8.11% 8.82% -8.11% -2.63% 0.00% 2.70% -
  Horiz. % 91.89% 100.00% 91.89% 100.00% 102.70% 102.70% 100.00%
Adjusted Per Share Value based on latest NOSH - 414,282
31/01/18 31/12/17 31/10/17 31/07/17 30/04/17 31/01/17 31/10/16 CAGR
RPS 5.16 - 5.19 5.94 5.66 6.95 2.89 58.88%
  QoQ % 0.00% 0.00% -12.63% 4.95% -18.56% 140.48% -
  Horiz. % 178.55% 0.00% 179.58% 205.54% 195.85% 240.48% 100.00%
EPS -0.18 0.00 0.26 0.33 0.26 0.24 0.07 -
  QoQ % 0.00% 0.00% -21.21% 26.92% 8.33% 242.86% -
  Horiz. % -257.14% 0.00% 371.43% 471.43% 371.43% 342.86% 100.00%
DPS 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -
  QoQ % 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -
  Horiz. % - - - - - - -
NAPS 0.2296 0.2385 0.2191 0.2159 0.2187 0.2186 0.2143 5.66%
  QoQ % -3.73% 8.85% 1.48% -1.28% 0.05% 2.01% -
  Horiz. % 107.14% 111.29% 102.24% 100.75% 102.05% 102.01% 100.00%
Price Multiplier on Financial Quarter End Date
31/01/18 31/12/17 31/10/17 31/07/17 30/04/17 31/01/17 31/10/16 CAGR
Date 30/01/18 29/12/17 31/10/17 31/07/17 28/04/17 31/01/17 31/10/16 -
Price 0.5250 0.5550 0.5500 0.5700 0.6200 0.4950 0.3850 -
P/RPS 6.87 0.00 6.82 5.60 6.31 4.10 7.73 -8.99%
  QoQ % 0.00% 0.00% 21.79% -11.25% 53.90% -46.96% -
  Horiz. % 88.87% 0.00% 88.23% 72.45% 81.63% 53.04% 100.00%
P/EPS -197.11 0.00 138.29 100.00 137.78 119.18 320.83 -
  QoQ % 0.00% 0.00% 38.29% -27.42% 15.61% -62.85% -
  Horiz. % -61.44% 0.00% 43.10% 31.17% 42.94% 37.15% 100.00%
EY -0.51 0.00 0.72 1.00 0.73 0.84 0.31 -
  QoQ % 0.00% 0.00% -28.00% 36.99% -13.10% 170.97% -
  Horiz. % -164.52% 0.00% 232.26% 322.58% 235.48% 270.97% 100.00%
DY 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -
  QoQ % 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -
  Horiz. % - - - - - - -
P/NAPS 1.54 1.50 1.62 1.54 1.63 1.30 1.04 36.83%
  QoQ % 2.67% -7.41% 5.19% -5.52% 25.38% 25.00% -
  Horiz. % 148.08% 144.23% 155.77% 148.08% 156.73% 125.00% 100.00%
Price Multiplier on Announcement Date
31/01/18 31/12/17 31/10/17 31/07/17 30/04/17 31/01/17 31/10/16 CAGR
Date 28/03/18 - 13/12/17 28/09/17 21/06/17 22/03/17 14/12/16 -
Price 0.5000 0.0000 0.5250 0.5700 0.6400 0.6500 0.4000 -
P/RPS 6.55 0.00 6.51 5.60 6.51 5.39 8.03 -15.02%
  QoQ % 0.00% 0.00% 16.25% -13.98% 20.78% -32.88% -
  Horiz. % 81.57% 0.00% 81.07% 69.74% 81.07% 67.12% 100.00%
P/EPS -187.73 0.00 132.01 100.00 142.22 156.50 333.33 -
  QoQ % 0.00% 0.00% 32.01% -29.69% -9.12% -53.05% -
  Horiz. % -56.32% 0.00% 39.60% 30.00% 42.67% 46.95% 100.00%
EY -0.53 0.00 0.76 1.00 0.70 0.64 0.30 -
  QoQ % 0.00% 0.00% -24.00% 42.86% 9.38% 113.33% -
  Horiz. % -176.67% 0.00% 253.33% 333.33% 233.33% 213.33% 100.00%
DY 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -
  QoQ % 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -
  Horiz. % - - - - - - -
P/NAPS 1.47 0.00 1.54 1.54 1.68 1.71 1.08 27.92%
  QoQ % 0.00% 0.00% 0.00% -8.33% -1.75% 58.33% -
  Horiz. % 136.11% 0.00% 142.59% 142.59% 155.56% 158.33% 100.00%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.


NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ Δ & YoY Δ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.



  Be the first to like this.
 


APPS
I3 Messenger
Individual or Group chat with anyone on I3investor
MQ Trader
Perform Technical & Fundamental Analysis on Stocks
MQ Affiliate
Earn rewards by referring your friends
 
 

184  450  568  1249 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 VC 0.05-0.005 
 AT 0.090.00 
 DATAPRP 0.20-0.02 
 MAHSING 0.99-0.01 
 KSTAR 0.445+0.075 
 DGSB 0.22+0.005 
 SUPERMX 9.780.00 
 SUPERMX-C1I 0.1550.00 
 VIVOCOM 0.0450.00 
 HWGB 0.77+0.055 

FEATURED POSTS

1. The Equity Market Index Benchmark in Malaysia CMS
2. Trading Scenarios of Derivatives Bursa Derivatives Education Series
3. Derivatives 101 Bursa Derivatives Education Series
4. Why Trade FKLI? Bursa Derivatives Education Series
5. MQ Trader - Introduction to MQ Trader Affiliate Program MQ Trader Announcement!

TOP ARTICLES

1. A LOOK AT CALVIN TAN RESEARCH STOCK PICKS (AS RECORDED BY PHILIP NOT PERFECTLY BUT CLEAR ENOUGH THE INVESTMENT APPROACH OF CALVIN TAN
2. Supermax: my revised target price - Koon Yew Yin Koon Yew Yin's Blog
3. Najib Facebook Post comments on GLOVES. What's the message? gloveharicut
4. US has 2 Incurable Chronic Diseases - Koon Yew Yin Koon Yew Yin's Blog
5. Supermax: The Best Is Yet To Come- Myth or Truth Van Gogh of Financial
6. LUXCHEM RESULT VERSUS HARTALEGA RESULT (COMPARE & CONTRAST) Calvin Tan Research THE INVESTMENT APPROACH OF CALVIN TAN
7. [Humbled Investor] Supermx - Superb results - Estimation on Next QR Results HumbledInvestor
8. DOW CRASHED BY 650 POINTS ? NO FEAR AT ALL IF YOU KNOW THIS STOCK PROSPERED DURING ASIAN FINANCIAL CRISIS & SUBPRIME CRISIS OF 2007/8 COLLAPSE (WHAT? THE INVESTMENT APPROACH OF CALVIN TAN
PARTNERS & BROKERS